Insider filing · INCY
Patrick A Mayes
EVP & Chief Scientific Officer
profile →
Incyte Corporation
INCY · Healthcare · 38 filings in 24 months
ticker →
Patrick A Mayes sold $531K of Incyte (INCY)
Executed Dec 10 2025, disclosed Dec 12 2025, 2 days later.
Value, as filed
$531K
5,553 sh × $95.58
Executed
Dec 10 2025
the trade date, as filed
Disclosed
Dec 12 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
PMPatrick A Mayes (EVP & Chief Scientific Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Incyte Corporation (INCY). The largest single filing was $5.7M of INCY (47,543 sh across 10 lots, as filed), executed Jul 31.
The name
INCYHealthcare · Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Patrick A Mayes in INCY
INCYSALE
Incyte Corporation
$274K2,207 sh × $123.99
Exec Aug 5
Filed Aug 7 · 4:01 PM ET INCYSALE Incyte Corporation $5.7M
47,543 sh across 10 lots
Exec Jul 31
Filed Aug 4 · 4:04 PM ET